Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4

2(33.3%)

N/A

2(33.3%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

6Total

Phase 4(2)

N/A(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07484802Not ApplicableNot Yet Recruiting

Vela Generation II: Usability and Performance of a Non-Invasive Ventilation Mask.

Role: collaborator

NCT05610085Phase 2Recruiting

A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

Role: collaborator

NCT03138941Recruiting

Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

Role: collaborator

NCT02140580Phase 4Unknown

OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP

Role: collaborator

NCT02739126Not ApplicableUnknown

Comparing the Diagnostic Yield of Radial EBUS Guided Biopsies When Using a Thick (1.7mm) Vs. Thin (1.4 mm) USS Probe.

Role: lead

NCT02395939Phase 3Unknown

Comparing Diagnostic Yield Between R-EBUS Guided Cryo Biopsy Vs. CT Guided Biopsy for PPL

Role: lead

NCT01252420Phase 4Unknown

Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis

Role: collaborator

All 7 trials loaded